Ocugen, Inc. Common Stock
€1.155
EUR
Last updated on --.
24h volume5.18M
24h highest1.2072 EUR
24h lowest1.1470 EUR
24h Price movement+0.37%
OCGN recent prices
24 Hours
+0.37%+€0.004296
30 days
-20.88%-€0.30502
60 days
-28.61%-€0.45967
90 days
-28.07%-€0.45108
Key data
Previous close1.1513 EUR
Market cap395.57M EUR
Volume5.18M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.13747 EUR
Net income (FY)-46.37M EUR
Revenue (FY)4.00M EUR
Last report date8 May 2026
About Ocugen, Inc. Common Stock
HeadquartersMALVERN
Employees (FY)116.00
Revenue per employee (FY)34.50K EUR
Net income per employee (FY)-399.73K EUR
Listed onNasdaq
OCGN conversion tables
 |  |
|---|---|
| 0.5 OCGN | 0.57781 EUR |
| 1 OCGN | 1.155 EUR |
| 5 OCGN | 5.778 EUR |
| 10 OCGN | 11.55 EUR |
| |
|---|---|
| 0.5 EUR | 0.43267 OCGN |
| 1 EUR | 0.86533 OCGN |
| 5 EUR | 4.326 OCGN |
| 10 EUR | 8.653 OCGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
OCGN is trading at €1.155, +0.37% over the last 24 hours. Track live moves on the price chart at the top of this page.
The OCGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. OCGN is currently trading at €1.155, +0.37% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on OCGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. OCGN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from OCGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against OCGN's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Ocugen, Inc. Common Stock's market cap is currently 395.57M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume5.18M
24h highest1.2072 EUR
24h lowest1.1470 EUR
24h Price movement+0.37%
Start trade with OCGN Perpetual
Sign up to trade